Company intelligence
Andelyn Biosciences
Accelerating the development and manufacturing of innovative therapies to bring more treatments to more patients.
About Andelyn Biosciences
Andelyn Biosciences is a gene therapy CDMO dedicated to Turning Hope Into Reality™. Founded out of Nationwide Children’s Hospital, we support the development and manufacturing of innovative cell and gene therapies with a deep sense of responsibility to our partners and the patients and families behind the science. With more than 20 years of experience in viral vector manufacturing, Andelyn offers clients access to deep scientific expertise and globally recognized thought leadership. We have produced GMP material for more than 75 worldwide clinical trials, over 450 cGMP clinical batches, and more than 2,000 research-grade productions. Our capabilities span viral vector process and analytical development, adherent and suspension-based GMP drug substance manufacturing up to 2,000L, GMP plasmid process development and manufacturing, advanced quality systems, and integrated supply chain capabilities. Located in Columbus, Ohio, our 180,000-square-foot clinical and commercial manufacturing facility supports programs from clinical through commercial scale, helping accelerate the delivery of therapies to patients who need them.
Verified activity
Signals from Andelyn Biosciences
2 published signals
Presence & Recognition
Andelyn Biosciences received the first US. investigational gene therapy for Duchenne muscular dystrophy in 2006.
Reported by Andelyn Biosciences
Partnerships
Andelyn Biosciences has been selected to support the scale-up manufacturing of Genprex, Inc.'s AAV-based diabetes gene therapy program through the Curator® Cell and Gene Therapy Platform.
Reported by Andelyn Biosciences